Finished product reference
Total Parentral Nutrition
Injection, Emulsion · Intravenous · 5 mg/7.4 mg/9.3 mg/4.3 mg/4.4 mg/6.2 mg/12 mg/3 mg/14 mg/11 mg/11.2 mg/6.5 mg/5.1 mg/2 mg/0.4 mg/1 mg/143 mg/0.74 mg/2.47 mg/4.48 mg/5.62 mg/4.18 mg/23 µg/60 mg/60 mg/30 mg/50 mg/1mL · 1904 mL
- List code
- 53024
- Pharmacologic class
- Parenteral nutrition (amino acid, glucose and lipid emulsion admixtures, often multi-chamber bags)
What it is and how it works
Total parenteral nutrition supplies the body’s requirements for protein (as amino acids), energy (as glucose and lipid emulsion), essential fatty acids and, with additives, electrolytes, vitamins and trace elements directly into the venous circulation, bypassing the gastrointestinal tract. Multi-chamber bags keep components separate until activated immediately before use.
Indications
Nutritional support in patients in whom oral or enteral nutrition is impossible, insufficient or contraindicated, e.g. intestinal failure, severe malabsorption, prolonged ileus, major gastrointestinal surgery or high-output fistulae.
Dosage and administration (summary)
Composition, volume and infusion rate are individualised by the nutrition team according to the patient’s weight, clinical condition, fluid and metabolic status; peripheral or central venous administration depends on osmolarity.
Contraindications
Hypersensitivity to egg, soya, fish or peanut proteins (depending on the lipid source) or other components; severe hyperlipidaemia; uncorrected severe metabolic disorders (e.g. metabolic acidosis, hyperglycaemia unresponsive to insulin, hyperosmolar states); congenital abnormalities of amino acid metabolism; unstable circulatory conditions such as shock.
Warnings and precautions
Monitor fluid and electrolyte balance, blood glucose, serum triglycerides, liver function and acid–base status regularly. Start cautiously in malnourished patients to avoid refeeding syndrome. Catheter-related infection, thrombosis and hepatobiliary complications may occur with long-term use; strict aseptic technique is essential.
Pregnancy
May be used in pregnancy when parenteral nutrition is clinically required.
Storage and supply
Store below 25 °C, do not freeze, and keep in the overwrap until use; after mixing chambers or adding additives, use promptly or as directed by the manufacturer.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
- Injection, Emulsion · Intravenous · 5 mg/7.4 mg/9.3 mg/4.3 mg/4.4 mg/6.2 mg/12 mg/3 mg/14 mg/11 mg/11.2 mg/6.5 mg/5.1 mg/2 mg/0.4 mg/1 mg/143 mg/0.74 mg/2.47 mg/4.48 mg/5.62 mg/4.18 mg/23 µg/60 mg/60 mg/30 mg/50 mg/1mL · 1206 mL53022
- Injection, Emulsion · Intravenous · 5 mg/7.4 mg/9.3 mg/4.3 mg/4.4 mg/6.2 mg/12 mg/3 mg/14 mg/11 mg/11.2 mg/6.5 mg/5.1 mg/2 mg/0.4 mg/1 mg/143 mg/0.74 mg/2.47 mg/4.48 mg/5.62 mg/4.18 mg/23 µg/60 mg/60 mg/30 mg/50 mg/1mL · 1448 mL53023
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.